Haemonetics Corp. (hae 0 03/01/26)
13F holders, Q3 2025 (September 30)10holders +1
3new positions
2sold out
$0.98avg. 13F price*
At the end of Q3 2025, 10 institutions reported holding Haemonetics Corp. (hae 0 03/01/26) in their 13F filings, up 1 from Q2 2025. 3 opened new positions and 2 sold out. The largest holders were Angelo Gordon & Co., L.P. ($5.9M), BNP PARIBAS ASSET MANAGEMENT Holding S.A. ($2.9M) and Sei Investments Co. ($327K).
- Company
- Haemonetics Corp. (hae 0 03/01/26)
- CUSIP
- 405024AB6
- Latest filing quarter
- Q4 2025
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $105K |
| Exits | 2 | $23K |
All 13F filers, Q2 2025 → Q3 2025: 111,000 shares bought and 24,000 shares sold, net +87,000 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 10 holders
| Angelo Gordon & Co., L.P. | 0.85% | No change | 6,000,000 | $5.9M |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 0.01% | No change | 3,000,000 | $2.9M |
| Sei Investments Co. | 0.00% | No change | 335,000 | $327K |
| Oppenheimer Asset Management Inc. | 0.00% | Add +1.6% | 192,000 | $188K |
| Financial Consulate, Inc. | 0.01% | New | 68,000 | $66K |
| Stephens Inc. | 0.00% | No change | 59,000 | $58K |
| LPL Financial LLC | 0.00% | No change | 40,000 | $39K |
| Wealthspire Advisors, LLC | 0.00% | New | 28,000 | $27K |
| Commonwealth Equity Services, LLC | 0.00% | No change | 20,000 | $20K |
| Fifth Third Bancorp | 0.00% | New | 12,000 | $12K |
"% of holder's portfolio" is HAEMONETICS CORP (HAE 0 03/01/26)'s weight in each manager's 13F, not the share of Haemonetics Corp. (hae 0 03/01/26) the manager owns.